Trial Profile
A Study of Efficacy and Safety of Telbivudine in Pregnancy for the Prevention of Perinatal Transmission of Hepatitis B HeVirus Infection.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Apr 2016
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 02 Nov 2010 Results were presented at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (Abstract No. 212), according to an AASLD media release.
- 01 Nov 2010 Primary endpoint 'Infection-rate' has been met, according to abstract presented at AASLD.
- 01 Nov 2010 Results were presented at the 61st Annual Meeting of the American Association for the Study of Liver Diseases.